Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02012231
Title Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Plexxikon

thyroid gland cancer


Advanced Solid Tumor

hairy cell leukemia



Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Scottsdale Healthcare Scottsdale Arizona 85258 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Evergreen Hematology & Oncology Spokane Washington 99218 United States Details
*Shaded cells indicate that there was no data available from for the field